Septerna (SEPN) Shareholder's Equity (2023 - 2026)

Septerna (SEPN) Shareholder's Equity (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 7.14 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 595,226.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - 502.95 Mn
10 Septerna 1.62 Bn 1.62 Bn - 378.46 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 378.46 Mn
Dec 31, 2025 381.93 Mn
Sep 30, 2025 388.73 Mn
Jun 30, 2025 377.56 Mn
Mar 31, 2025 -400.27 Mn
Dec 31, 2024 420.05 Mn
Sep 30, 2024 -87.41 Mn
Jun 30, 2024 -67.76 Mn
Mar 31, 2024 -51.89 Mn
Dec 31, 2023 -38.37 Mn
Sep 30, 2023 -73.85 Mn